Mobidiag Looks Inward To Solve COVID-19 Test Manufacturing Challenges
With diagnostic companies facing supply chain issues and reagent shortages for COVID-19 tests, Finnish diagnostics company Mobidiag decided to take matters into its own hands. CEO Tuomas Tenkanen tells Medtech Insight how the company secured manufacturing capabilities in-house.
You may also be interested in...
Finnish diagnostics company Mobidiag has launched its new joint venture with partner Autobio Diagnostics called Automobi.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.